Pre-clinical Formulation Development of an in situ Meglumine Salt of AZD5991: A Novel Macrocyclic Mcl-1 Inhibitor
Crossref DOI link: https://doi.org/10.1007/s11095-023-03503-2
Published Online: 2023-04-03
Published Print: 2023-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Yang, Wenzhan http://orcid.org/0000-0002-4591-5007
Cook, Steve
Wu, Dedong
Text and Data Mining valid from 2023-04-01
Version of Record valid from 2023-04-01
Article History
Received: 2 November 2022
Accepted: 20 March 2023
First Online: 3 April 2023
Declarations
:
: There are no conflicts of interest to disclose.